MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$110,528K
(-7.61%↓ Y/Y)
Cash and cash
equivalents
$22,808K
(10.99%↑ Y/Y)
Prepaid expenses and
other current assets
$2,352K
(-33.78%↓ Y/Y)
Total current assets
$135,688K
(-5.60%↓ Y/Y)
In-process research and
development
$32,386K
(0.00%↑ Y/Y)
Operating lease
right-of-use asset, net
$613K
(-33.80%↓ Y/Y)
Other assets
$322K
(-11.29%↓ Y/Y)
Total assets
$169,009K
(-4.73%↓ Y/Y)
Total liabilities,
convertible preferred stock...
$169,009K
(-4.73%↓ Y/Y)
Total stockholders'
equity
$81,085K
(29.85%↑ Y/Y)
Convertible preferred
stock, value-Series...
$53,543K
(0.00%↑ Y/Y)
Total liabilities
$32,230K
(-45.62%↓ Y/Y)
Convertible preferred
stock, value-Series...
$2,151K
(0.00%↑ Y/Y)
Accumulated deficit
-$401,203K
(-12.83%↓ Y/Y)
Additional paid-in capital
$482,189K
(15.37%↑ Y/Y)
Total current
liabilities
$18,344K
(58.45%↑ Y/Y)
Warrant liabilities
$11,416K
(-74.55%↓ Y/Y)
Deferred tax liability
$2,187K
(0.18%↑ Y/Y)
Non-current operating lease
liability
$283K
(-55.78%↓ Y/Y)
Common stock, 0.001 par
value, 300,000,000 and...
$75K
(25.00%↑ Y/Y)
Accumulated other
comprehensive income
$24K
(-7.69%↓ Y/Y)
Accrued expenses and
other liabilities
$14,359K
(164.44%↑ Y/Y)
Accounts payable
$3,627K
(-37.82%↓ Y/Y)
Current operating lease
liability
$358K
(14.01%↑ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
Eledon Pharmaceuticals, Inc. (ELDN)
Eledon Pharmaceuticals, Inc. (ELDN)